Argo PL Sp. z o.o.
- Address
- Ul. Dr Seweryna Sterlinga 27/29, 90-212 Lodz, Poland
Argo PL Sp. z o.o. - Infectious Disease Research Center
Argo PL Sp. z o.o. is a specialized clinical research facility focused on advanced antimicrobial therapies and infectious disease management. The center demonstrates particular expertise in conducting complex Phase 3 trials that evaluate novel antibiotic treatments for challenging bacterial infections, with emphasis on conditions affecting vulnerable patient populations.
- Advanced antibiotic development and comparative efficacy studies
- Diabetic foot infections and complications in metabolic disease patients
- Safety and tolerability assessments of intravenous and oral antimicrobial agents
The research center specializes in randomized, double-blind, multicenter trials designed to evaluate both safety and clinical efficacy outcomes. Their work includes comprehensive assessment of investigator-evaluated clinical responses and detailed tolerability profiles, particularly for new oxazolidinone antibiotics and their comparison to established treatments like linezolid in moderate to severe infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Mediwound Ltd.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Argo PL Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of 5% EscharEx (Concentrate of Proteolytic Enzymes Enriched in Bromelain) in Debridement of Venous Leg Ulcers | Mediwound Ltd. | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| F1245/05 | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.